IL6 and Fabry disease: In the present study we have evaluated biomarkers for cardiac fibrosis (Gal-3), cardiac wall stress (NT-proBNP), myocardial injury (hsTnT), renal function (BTP) or inflammation (IL-6) in patients with FD.